Privium Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.75M | Hold |
8,300
| – | – | 0.81% | 18 |
|
|
2025
Q1 | $4.02M | Buy |
+8,300
| New | +$4.02M | 1.05% | 19 |
|
|
2024
Q1 | – | Sell |
-15,116
| Closed | -$6.21M | – | 129 |
|
|
2023
Q4 | $6.21M | Sell |
15,116
-6,279
| -29% | -$2.58M | 1.73% | 19 |
|
|
2023
Q3 | $7.44M | Sell |
21,395
-9,515
| -31% | -$3.31M | 2.21% | 12 |
|
|
2023
Q2 | $10.8M | Sell |
30,910
-1,560
| -5% | -$543K | 3.1% | 9 |
|
|
2023
Q1 | $10.2M | Sell |
32,470
-2,837
| -8% | -$894K | 3.44% | 7 |
|
|
2022
Q4 | $10.2M | Buy |
35,307
+6,807
| +24% | +$1.97M | 3.87% | 9 |
|
|
2022
Q3 | $8.35M | Buy |
28,500
+500
| +2% | +$146K | 3.03% | 9 |
|
|
2022
Q2 | $7.89M | Hold |
28,000
| – | – | 2.61% | 12 |
|
|
2022
Q1 | $7.31M | Sell |
28,000
-3,000
| -10% | -$783K | 1.62% | 19 |
|
|
2021
Q4 | $6.9M | Buy |
+31,000
| New | +$6.9M | 1.37% | 24 |
|